Phio Pharmaceuticals Corp.
PHIO | NASDAQ
$1.01
-$0.02 (-1.94%)
At close: Sep 21, 2026, 4:00 PM ET
$1.06
+$0.05 (+4.95%)
Pre-market:
Sep 22, 2026, 6:21 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 2.66M | 3.73M | 3.75M | 3.26M | 2.72M | 2.51M | 3.64M | 2.7M | 3.87M | 3.05M | 4.03M | 5.61M | 6.31M | 7.56M | 7.01M | 7.62M | 7.79M | 6.48M | 7.33M | 5.15M | 3.73M | 4.51M |
Gross Profit | -2.66M | -3.73M | -3.75M | -3.26M | -2.72M | -2.51M | -3.64M | -2.7M | -3.87M | -3.05M | -4.03M | -5.61M | -6.31M | -7.56M | -7.01M | -7.62M | -7.79M | -6.48M | -7.33M | -5.15M | -3.73M | -4.51M |
Operating Income | -9.21M | -11.52M | -9.22M | -8.36M | -7.45M | -7.05M | -7.39M | -7.49M | -8.67M | -9.31M | -10.7M | -11.66M | -12.45M | -12.42M | -11.46M | -12.18M | -12.35M | -12.51M | -13.51M | -12.52M | -11.09M | -10.08M |
Interest Income | 161K | 280K | 244K | 475K | 475K | 356K | 231K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -12.9M | -10.93M | -8.7M | -7.95M | -7.09M | -6.77M | -7.15M | -7.42M | -8.68M | -9.38M | -10.83M | -11.66M | -12.46M | -12.44M | -11.48M | -12.2M | -12.37M | -12.52M | -13.29M | -12.3M | -10.87M | -9.85M |
Net Income | -12.9M | -10.93M | -8.7M | -7.95M | -7.09M | -6.77M | -7.15M | -7.42M | -8.68M | -9.38M | -10.83M | -11.66M | -12.46M | -12.44M | -11.48M | -12.2M | -12.37M | -12.52M | -13.29M | -12.3M | -10.87M | -9.85M |
Selling & General & Admin | 4.94M | 4.99M | 4.6M | 4.23M | 3.86M | 3.67M | 3.74M | 3.78M | 3.8M | 3.92M | 4.32M | 4.72M | 4.81M | 4.86M | 4.45M | 4.56M | 4.56M | 4.47M | 4.63M | 4.64M | 4.62M | 4.39M |
Research & Development | 8.53M | 6.53M | 4.62M | 4.13M | 3.59M | 3.38M | 3.64M | 3.66M | 4.83M | 5.35M | 6.33M | 6.94M | 7.64M | 7.56M | 7.01M | 7.62M | 7.79M | 8.04M | 8.89M | 7.84M | 6.42M | 5.64M |
Other Expenses | -2.66M | -3.73M | -3.75M | -3.26M | -2.72M | -2.51M | -3.64M | -2.66M | -3.82M | -3.01M | -3.99M | -5.61M | -6.31M | -7.56M | -7.01M | -7.62M | -7.79M | -6.48M | -7.33M | -5.1M | -3.69M | -4.46M |
Operating Expenses | 10.82M | 7.78M | 5.47M | 5.11M | 4.73M | 4.54M | 3.74M | 4.79M | 4.81M | 6.26M | 6.66M | 6.05M | 6.15M | 4.86M | 4.45M | 4.56M | 4.56M | 6.03M | 6.18M | 7.38M | 7.36M | 5.57M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5K | 15K | 17K | 18K | 16K | 9K | 9K | 8K | 8K | 8K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 9.21M | 11.52M | 9.22M | 8.36M | 7.45M | 7.05M | 7.39M | 7.49M | 8.67M | 9.31M | 10.7M | 11.66M | 12.45M | 12.42M | 11.46M | 12.18M | 12.35M | 12.51M | 13.51M | 12.52M | 11.09M | 10.08M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 11.62M | 11.62M | 11.62M | 5.47M | 4.79M | 4.31M | 787.47K | 990.03K | 510.19K | 508.39K | 415.95K | 270.86K | 191.86K | 126.79K | 126.43K | 126.38K | 126.34K | 125.47K | 125.19K | 125.19K | 125.19K | 98.79K |
Shares Outstanding (Diluted) | 11.62M | 11.62M | 11.62M | 5.47M | 4.79M | 4.31M | 787.47K | 990.03K | 510.19K | 508.39K | 415.95K | 270.86K | 191.86K | 126.79K | 126.43K | 126.38K | 126.34K | 125.47K | 125.19K | 125.19K | 125.19K | 98.79K |
EPS (Basic) | -1.34 | -1.43 | -41.07K | -41.07K | -41.07K | -41.08K | -9.77 | -13.96 | -22.68 | -32.35 | -56.52 | -72.48 | -90.55 | -97.37 | -90.03 | -97.08 | -98.64 | -99.99 | -113.41 | -131.89 | -145.18 | -160.12 |
EPS (Diluted) | -1.34 | -1.43 | -41.07K | -41.07K | -41.07K | -41.08K | -9.77 | -13.96 | -22.68 | -32.35 | -56.52 | -72.48 | -90.55 | -97.37 | -90.03 | -97.08 | -98.64 | -99.99 | -113.41 | -131.89 | -145.18 | -160.12 |
EBITDA | -8.76M | -10.93M | -8.69M | -7.91M | -7.04M | -6.72M | -7.07M | -7.34M | -8.58M | -9.27M | -10.74M | -11.6M | -12.39M | -12.36M | -11.39M | -12.11M | -12.27M | -12.43M | -13.44M | -12.42M | -10.99M | -9.98M |
EBIT | -8.77M | -10.93M | -8.7M | -7.95M | -7.09M | -6.77M | -7.15M | -7.42M | -8.68M | -9.38M | -10.83M | -11.66M | -12.45M | -12.43M | -11.46M | -12.18M | -12.35M | -12.51M | -13.51M | -12.52M | -11.09M | -10.08M |
Depreciation & Amortization | 4K | 4.5K | 3.5K | 44.5K | 42.5K | 43K | 77K | 78K | 93K | 107K | 89K | 61K | 61K | 65K | 71K | 76K | 80K | 79K | 75K | 100K | 99K | 100K |
Add to Watchlist
Select watchlists to add or remove PHIO